Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blatt, Stephen P., Yultyev, Aleksandr, Huang, Miao, Friedstrom, Scott, Steinbrunner, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132653/
https://www.ncbi.nlm.nih.gov/pubmed/28865937
http://dx.doi.org/10.1016/j.ajic.2017.07.019
Descripción
Sumario:We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.

Ejemplares similares